Century Therapeutics
IPSCCentury Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brent Pfeiffenberger, with a market cap of $416.6M.
$416.62M+682%
We’re still putting together Century Therapeutics’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.
Ask us to move Century Therapeutics up the queue, and we’ll analyze its filings next.
Earnings
Next report
Aug 13, 2026 (in a month)Revenue estimate$2.2M
EPS estimate-$0.11
Profile
CountryUnited States of America
Listed2021
Employees165.0
CEOBrent Pfeiffenberger
SectorHealthcare
IndustryBiotechnology
Websitecenturytx.com
FilingsSEC EDGAR